HighTower Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Sell
6,826
-7,405
-52% -$381K ﹤0.01% 3155
2026
Q1
$843K Sell
14,231
-7,998
-36% -$519K ﹤0.01% 2307
2025
Q4
$1.37M Sell
22,229
-582
-3% -$35.6K ﹤0.01% 1912
2025
Q3
$1.42M Sell
22,811
-12,912
-36% -$899K ﹤0.01% 1857
2025
Q2
$2.85M Buy
35,723
+5,359
+18% +$448K ﹤0.01% 1375
2025
Q1
$2.61M Sell
30,364
-1,302
-4% -$107K ﹤0.01% 1379
2024
Q4
$2.47M Buy
31,666
+14,958
+90% +$1.16M ﹤0.01% 1394
2024
Q3
$1.22M Buy
16,708
+774
+5% +$54.8K ﹤0.01% 1808
2024
Q2
$1.1M Buy
15,934
+137
+0.9% +$9.28K ﹤0.01% 1791
2024
Q1
$1.15M Buy
15,797
+1,087
+7% +$72.7K ﹤0.01% 1729
2023
Q4
$904K Buy
14,710
+1,145
+8% +$68K ﹤0.01% 1898
2023
Q3
$778K Sell
13,565
-269
-2% -$16.3K ﹤0.01% 1938
2023
Q2
$822K Buy
13,834
+976
+8% +$58.4K ﹤0.01% 1871
2023
Q1
$819K Buy
12,858
+624
+5% +$39K ﹤0.01% 1797
2022
Q4
$781K Buy
12,234
+6,644
+119% +$381K ﹤0.01% 1821
2022
Q3
$279K Buy
5,590
+162
+3% +$8.97K ﹤0.01% 2392
2022
Q2
$319K Sell
5,428
-363
-6% -$20K ﹤0.01% 2315
2022
Q1
$307K Buy
5,791
+330
+6% +$19.1K ﹤0.01% 2510
2021
Q4
$331K Buy
5,461
+54
+1% +$3.21K ﹤0.01% 2421
2021
Q3
$302K Buy
5,407
+4
+0.1% +$220 ﹤0.01% 2408
2021
Q2
$281K Buy
5,403
+3
+0.1% +$144 ﹤0.01% 2415
2021
Q1
$238K Buy
+5,400
New +$227K ﹤0.01% 2465
2020
Q3
Sell
-5,444
Closed -$206K 2651
2020
Q2
$206K Buy
+5,444
New +$218K ﹤0.01% 1978
2020
Q1
Sell
-5,448
Closed -$219K 2421
2019
Q4
$219K Sell
5,448
-29,483
-84% -$1.1M ﹤0.01% 1914
2019
Q3
$1.21M Buy
+34,931
New +$1.15M 0.01% 1084

Other funds holding PBH

HighTower Advisors's PBH Position: Q2 2026 in Review

HighTower Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 52% in Q2 2026, selling an estimated $381K and leaving 6,826 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

HighTower Advisors first reported a position in PBH in Q3 2019 and has held it in 25 quarters since. The position peaked at $2.85M in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • HighTower Advisors held 6,826 shares of Prestige Consumer Healthcare worth $323K as of Q2 2026.
  • HighTower Advisors sold 7,405 Prestige Consumer Healthcare shares in Q2 2026, an estimated $381K.
  • Prestige Consumer Healthcare made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3155 holding.
  • HighTower Advisors first reported a position in Prestige Consumer Healthcare in Q3 2019 and has held it in 25 quarters since.
  • HighTower Advisors's Prestige Consumer Healthcare position peaked at $2.85M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.